» Articles » PMID: 22414874

Notch Signaling in Diabetic Nephropathy

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2012 Mar 15
PMID 22414874
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Notch signaling is an evolutionarily conserved cell-cell signaling system that controls the fate of cells during development. In this review, we will summarize the literature that notch signaling during development controls nephron number and segmentation and therefore could influence kidney disease susceptibility. We will also review the evidence that Notch is reactivated in adult-onset diabetic kidney disease where it promotes the development of nephropathy including glomerulopathy, tubulointerstitial fibrosis and possibly arteriopathy and inflammation. Finally, we will review the evidence that blockade of pathogenic Notch signaling alters the natural history of diabetic nephropathy and thus could represent a novel therapeutic approach to the management of diabetic kidney disease.

Citing Articles

Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes.

Craig-Schapiro R, Li G, Chen K, Gomez-Salinero J, Nachman R, Kopacz A Nat Commun. 2025; 16(1):1338.

PMID: 39915484 PMC: 11802906. DOI: 10.1038/s41467-024-55415-3.


Kidney Injury: Focus on Molecular Signaling Pathways.

Liu W, Hu M, Wang L, Mirzaei H Curr Med Chem. 2024; 31(28):4510-4533.

PMID: 38314680 DOI: 10.2174/0109298673271547231108060805.


Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy.

Liu S, Wang H, Yang B, Hou B, Sun L, Pang H J Diabetes Investig. 2023; 15(2):159-171.

PMID: 37985406 PMC: 10804928. DOI: 10.1111/jdi.14107.


Epsin1-mediated exosomal sorting of Dll4 modulates the tubular-macrophage crosstalk in diabetic nephropathy.

Liu J, Zhang L, Huang Y, Li X, Liu Y, Zhang S Mol Ther. 2023; 31(5):1451-1467.

PMID: 37016580 PMC: 10188907. DOI: 10.1016/j.ymthe.2023.03.027.


Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy.

Yan Q, Zhao Z, Liu D, Li J, Pan S, Duan J Front Endocrinol (Lausanne). 2022; 13:1032814.

PMID: 36387855 PMC: 9642911. DOI: 10.3389/fendo.2022.1032814.


References
1.
Zheng X, Linke S, Dias J, Zheng X, Gradin K, Wallis T . Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A. 2008; 105(9):3368-73. PMC: 2265116. DOI: 10.1073/pnas.0711591105. View

2.
Li L, Krantz I, Deng Y, Genin A, Banta A, Collins C . Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997; 16(3):243-51. DOI: 10.1038/ng0797-243. View

3.
Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller C, Muller G . The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract. 1991; 187(2-3):251-9. DOI: 10.1016/s0344-0338(11)80780-6. View

4.
Niranjan T, Murea M, Susztak K . The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol. 2009; 111(4):e73-9. PMC: 2851161. DOI: 10.1159/000209207. View

5.
Wiggins R . The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007; 71(12):1205-14. DOI: 10.1038/sj.ki.5002222. View